Your Biologics. Elevated.®

We develop and manufacture your biopharmaceutical drug candidate – reliably and rapidly. Our innovative technologies can elevate your product to the highest yield, potency, quality, and safety levels.

Learn More

Welcome to ProBioGen

We are a Contract Development and Manufacturing Organization (CDMO) and technology provider with extensive expertise in cell line engineering, process development, and GMP manufacturing of biopharmaceuticals. Our proprietary technologies accelerate and advance the development of drug candidates – from their inception to industrial market-readiness.

Therapeutic Proteins & Antibodies

Whether you want to produce an antibody, a therapeutic enzyme, or a virus, ProBioGen is your trusted and highly experienced partner for development and manufacturing. Starting with unique cell lines and all the way to scalable production, our process is tailored to your individual requirements. Expect best-in-class efficiency and competitive timelines combined with excellent customer service. We commit to top results and transparency at every stage.

GMP Production
Cell Lines

Get the best-performing, stable production cell line, customized to your specific molecule. Highest quality, delivered on time.

GMP Production
Cell Lines

Process
Development

High performance, fully scalable from mg to kg

Process
Development

Virus Production
Development

Benefit from our virus, cell line, and process experience.

Virus Production
Development

GMP
Manufacturing

Quality – consistency – compliance

GMP
Manufacturing

Biosimilars
& Biobetters

Accelerate market entry with a top performing protein

Biosimilars
& Biobetters

Analytics /
Bioassays

Leading-edge assays that reveal everything about your protein

Analytics /
Bioassays

Innovative Technologies

Enhancing the performance of antibodies by stripping them of fucose, linking antibodies to their drug loads at multiple targeted sites, testing the recombinant protein’s immunogenicity and function in-vitro, increasing productivity to unprecedented levels, or even boosting your viral vector or vaccine – our innovative technologies make those wishes your reality.

Genetic Glyco-Engineering/
ADCC (GlymaxX®)

Boost your antibodies’ potency with our GlymaxX ADCC enhancement technology

Genetic Glyco-Engineering/
ADCC (GlymaxX®)

DirectedLuck® Transposase
with Epigenetic Targeting

Give your protein a ride on a cellular engine

DirectedLuck® Transposase
with Epigenetic Targeting

Productivity
Increase

One gene to boost them all – see how you can optimize your titers with our proven Pathway Modulator

Productivity
Increase

Viral Vector
Technologies

ProBioGen's MVA platform – the most efficient production system for a potent vaccine vector

Viral Vector
Technologies

Virus Production
Cell Lines

A scalable cell line is the bedrock of industrial production. See what our high-yield lines can do for your virus or vector!

Virus Production
Cell Lines

Lenti.RiGHT®
Lentivirus Packaging and Producer Cell Line

Enables a scalable production of high-titer lentiviral particles for gene transfer applications.

Lenti.RiGHT®
Lentivirus Packaging and Producer Cell Line

Latest News

Upcoming Events

CPHI Europe

Milan, Italy

Miltenyi Cell and Gene Therapy Summit 2024

Bergisch Gladbach, Germany

Festival of Biologics Basel

Basel, Switzerland

 

Booth #802

 

Do not miss our poster #48 "DirectedLuck® Transposase Targeting and Transposon Design push Expression beyond Limits".

visit website

ESGCT Congress

Rome, Italy

 

Do not miss our poster "Lenti.RiGHT® – Epigenetic targeting delivers cutting-edge lentivirus producer cell lines"

visit website

World Vaccine Congress Europe

Barcelona, Spain

 

Dr Volker Sandig, CSO at ProBioGen, will hold a 15-minute presentation in the "Technology Showcases" track on Tuesday, October 29th at 13:30 CET

visit website

BIO-Europe

Stockholm, Sweden

PEGS Europe

Barcelona, Spain

 

Booth # 1304

 

Dr Thomas Rose, Head of Expression Systems at ProBioGen, will hold a 15-minute presentation in the track "Engineering Antibodies & Beyond" on Wednesday, November 6th at 17:15 CET

 

Do not miss our poster "DirectedLuck® Transposase Targeting and Transposon Design push Expression beyond Limits".

visit website

Your Objectives

Are you looking to enhance your program or are you just curious about our company, services, and technologies? Connect with our team and we will get back to you shortly.